共 247 条
[1]
Eastell R(2003)Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate J Bone Miner Res 18 1051-1056
[2]
Barton I(2009)Teriparatide reduces bone microdamage accumulation in postmenopausal women previously treated with alendronate J Bone Miner Res 24 1998-2006
[3]
Hannon RA(2010)Effects of 1 year of daily teriparatide treatment on iliacal bone mineralization density distribution (BMDD) in postmenopausal osteoporotic women previously treated with alendronate or risedronate J Bone Miner Res 25 2297-2303
[4]
Chines A(2010)Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research J Bone Miner Res 25 2267-2294
[5]
Garnero P(2015)The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM extension study Osteoporos Int 26 2773-2783
[6]
Delmas PD(1999)Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators JAMA 282 637-645
[7]
Dobnig H(2001)Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis N Engl J Med 344 1434-1441
[8]
Stepan JJ(2010)Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus Osteoporos Int 21 195-214
[9]
Burr DB(2006)Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats Osteoporos Int 17 1514-1523
[10]
Li J(2011)Changes in the contents of enzymatic immature, mature, and non-enzymatic senescent cross-links of collagen after once-weekly treatment with human parathyroid hormone (1-34) for 18 months contribute to improvement of bone strength in ovariectomized monkeys Osteoporos Int 22 2373-2383